相似化合物
30766-11-1 2404734-24-1 1289210-83-8欧盟法规
C&L通报上下游产品
CAS号30766-11-1 5-溴-2-羧基吡啶 | CAS号75-65-0 叔丁醇 | CAS号29682-15-3 5-溴吡啶-2-羧酸甲酯 | CAS号30766-11-1 5-溴-2-羧基吡啶 | CAS号1354356-24-3 5-(4,4,5,5-四甲基-... | CAS号1214339-84-0 [3,3'-联吡啶]-6-羧酸合成工艺路线路线简述
- 29682-15-3 = 845306-08-3
反应条件:1.1 Reagents: Butyllithium Solvents: Tetrahydrofuran,Hexane; 0 °C; 10 Min,0 °C1.2 Solvents: Tetrahydrofuran; 1 H,0 °C
标题:Direct C-2 Arylation Of Alkyl 4-Thiazolecarboxylates: New Insights In Synthesis Of Heterocyclic Core Of Thiopeptide Antibiotics
作者:Martin,Thibaut; Et Al
参考文献:Organic Letters 日期:2008 卷标:10(13) 页码:2909-2912]
24424-99-5 + 30766-11-1 = 845306-08-3
反应条件:1.1 Catalysts: 4-(Dimethylamino)Pyridine Solvents: Toluene; 0 °C; 20 H,50 °C
标题:Total Synthesis Of Micrococcin P1 And Thiocillin I Enabled By Mo(Vi) Catalyst
作者:Akasapu,Siddhartha; Et Al
参考文献:Chemical Science 日期:2019 卷标:10(7) 页码:1971-1975
📜5-溴-2-吡啶羧酸置于4-二甲氨基吡啶体系中,用 叔丁醇 作为反应溶剂,化学反应生成 5-溴吡啶甲酸叔丁酯
参考文献:Androgen Receptor Modulating Carboxamides
标题:Androgen Receptor Modulating Carboxamides
摘要:式(I)或(II)的化合物 其中r X,R Z,R 9,R 10,R 14,R 14 ',R 15,R 15 ',A和b如权利要求中所定义,并且其药学上可接受的盐和酯已被披露.这些化合物具有作为组织选择性雄激素受体调节剂(sarm)的效用,并且在治疗前列腺癌和其他依赖于ar的疾病和病症中,需要ar拮抗作用时可用作药物.
海关参考信息
- 2905122000-异丙醇
2905143000-叔丁醇
2912110000-甲醛
2915110000-甲酸 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-7884125-B2
优先权日:2008-04-30
标 题:Straightforward entry to 7-azabicyclo[2.2.1]heptane-1-carbonitriles and subsequent synthesis of epibatidine analogues
发明人:STEVENS CHRISTIAN; HEUGEBAERT THOMAS
权利人:UNIV GENT
摘要:The present invention relates to a group of substituted-7-azabicyclo-[2.2.1]heptyl derivatives with biological activity. The present invention also relates to synthetic methods for producing said substituted-7-azabicyclo-[2.2.1]heptyl derivatives. The present invention also relates to certain intermediates for producing such substituted-7-azabicyclo-[2.2.1]heptyl derivatives, as well as a synthetic method for producing such intermediates. The present invention also relates to pharmaceutical compositions comprising such substituted-7-azabicyclo-[2.2.1]heptyl derivatives, as well as their use as medicaments for the treatment of diseases mediated by a Nicotinic Acetylcholine Receptor or a receptor being a member of the Neurotransmitter-gated Ion Channel Superfamily, such as pain, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy and nicotine addiction.
专利号:US-2009275616-A1
优先权日:2008-04-30
标 题 :Straightforward entry to 7-azabicyclo[2.2.1]heptane-1-carbonitriles and subsequent synthesis of epibatidine analogues
专利号:US-9744173-B2
优先权日:2014-04-10
标题 :2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
发明人:BRODNEY MICHAEL AARON; BECK ELIZABETH MARY; BUTLER CHRISTOPHER RYAN; ZHANG LEI; O'NEILL BRIAN THOMAS; BARREIRO GABRIELA; LACHAPELLE ERIK ALPHIE; ROGERS BRUCE NELSEN
权利人:PFIZER
摘要:The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, n nand the variable R 1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.